Otophylloside A has shown potential in anti-inflammatory applications, particularly in the inhibition of nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated microglial cells. This suggests its possible use in managing neuroinflammatory conditions. It may also contribute to the protection of neuronal cells by modulating inflammatory pathways in the central nervous system. Due to its natural origin and observed bioactivity, it is being studied for its role in developing therapeutics for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. Additionally, otophylloside A exhibits antioxidant properties, which can help reduce oxidative stress, a key factor in aging and various chronic diseases. Its application is primarily focused on pharmaceutical research and development, especially in designing novel compounds with enhanced neuroprotective effects.